Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Digital Mirror Therapy With Uni- and Bilateral Mirror Visual Feedback After Stroke: Treatment Effects and EEG Evidence

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04813120
Recruitment Status : Recruiting
First Posted : March 24, 2021
Last Update Posted : March 10, 2022
Sponsor:
Information provided by (Responsible Party):
Chang Gung Memorial Hospital

Brief Summary:

The specific study aims will be:

  1. To examine the treatment effects of a new digital mirror therapy (MT) system versus a mirror box in patients with stroke by conducting a 4-group randomized controlled trial.
  2. To examine the electrophysiological mechanisms of uni-mirror visual feedback (uni-MVF) condition with unimanual training mode, uni-MVF condition with bimanual training mode, and bi-MVF condition with bimanual training mode in the new MT system by EEG.

Condition or disease Intervention/treatment Phase
Stroke Cerebrovascular Disorders Central Nervous System Diseases Behavioral: Uni-MVF condition and unimanual training mode using the new MT system (UM-UT) Behavioral: Uni-MVF condition and bimanual training mode using the new MT system (UM-BT) Behavioral: Bi-MVF condition and bimanual training mode using the new MT system (BM-BT) Behavioral: Traditional MT using a mirror box Not Applicable

Detailed Description:

Part I: Validation of Treatment Efficacy of the New Digital MT System with Different MVF Conditions and Training Modes

In this new MT system, 3 different types of MT in different MVF conditions and training modes can be provided: unilateral MVF with unimanual training mode (UM-UT), unilateral MVF with bimanual training mode (UM-BT), and bilateral MVF with bimanual training mode (BM-BT). In the part Ⅰ study, an estimated total of 80 patients with stroke will be recruited. In addition to the original rehabilitation interventions of patients, each participant will be randomly allocated to 1 of 4 intervention groups (i.e., UM-UT, UM-BT, BM-BT, or traditional MT using a mirror box) for 15-hour therapy sessions. Outcome measures will be administrated at pre-treatment, immediately after treatment, and at 1-month follow-up after treatment.

Part II: Investigation of the Electrophysiological Mechanisms Underlying Different MVF Conditions by EEG

Twenty stroke patients will be recruited for examining the brain electrophysiological mechanisms underlying different types of MVF and training conditions of this new system by using electroencephalography (EEG). Three experimental conditions, including UM-UT, UM-BT, and BM-BT conditions, will be conducted in the EEG study.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 80 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Other
Official Title: The Use of a New Digital Mirror Therapy System Providing Unilateral and Bilateral Mirror Visual Feedback for Patients With Stroke: Treatment Effects and EEG-physiological Evidence
Actual Study Start Date : August 1, 2021
Estimated Primary Completion Date : July 31, 2024
Estimated Study Completion Date : July 31, 2024

Arm Intervention/treatment
Experimental: Uni-MVF condition and unimanual training mode using the new MT system (UM-UT)
The following common categories of upper-limb movements and actions will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movements, and (c) object manipulation.
Behavioral: Uni-MVF condition and unimanual training mode using the new MT system (UM-UT)
For the UM-UT group, the participants will be seated in front of the new MT system, and will be instructed to watch the real-time image reflection of movements of the non-affected arm and hand on the screen carefully. At the same time, the patients will need to imagine that the movements were performed by their affected arm and hand. In this group, only the non-affected arm and hand will need to perform the movements, but the affected one will not need to move.

Experimental: Uni-MVF condition and bimanual training mode using the new MT system (UM-BT)
The following common categories of upper-limb movements and actions will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movements, and (c) object manipulation.
Behavioral: Uni-MVF condition and bimanual training mode using the new MT system (UM-BT)
During the UM-BT, as similar as the first group (UM-UT), the participants will be also seated in front of the new MT system, and be instructed to watch the real-time image reflection of the non-affected arm and hand's movements on the screen carefully and imagine that the movements were performed by the affected arm. However, in this UM-BT group, the bilateral training mode is emphasized, and thus both arms and hands will need to move. That is, during therapy, the patient's affected arm and hand will be required to move at his/her best motor ability with the non-affected arm and hand at the same time.

Experimental: Bi-MVF condition and bimanual training mode using the new MT system (BM-BT)
The following common categories of upper-limb movements and actions will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movements, and (c) object manipulation.
Behavioral: Bi-MVF condition and bimanual training mode using the new MT system (BM-BT)
For the BM-BT group, the participants will be seated in front of this new MT system, and be instructed to observe the real-time image reflection of the non-affected arm and hand's movements transformed and superimposed on both arms and hands (i.e., bi-MVF), and to imagine that the movements were performed by both arms and hands. In this group, bi-MVF and bilateral training mode are emphasized, and thus both arms and hands will also need to move. The patient's affected arm and hand will be required to move as could as possible simultaneously.

Active Comparator: Traditional MT using a mirror box
The following common categories of upper-limb movements and actions will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movements, and (c) object manipulation.
Behavioral: Traditional MT using a mirror box
During traditional MT, the participants will be seated in front of a mirror box placed at their mid-sagittal plane. The affected arm and hand of the participants will be placed inside the mirror box, and the non-affected arm and hand will be in front of the mirror. As similar to the UM-UT group, the participants will be instructed to watch the mirror reflection of the movements performed by the non-affected arm and hand carefully and to imagine that the movements were performed by the affected arm and hand. In this group, the patient's affected arm and hand inside the mirror box will not need to move.




Primary Outcome Measures :
  1. Change scores of Fugl-Meyer Assessment [ Time Frame: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2) ]
    The upper-limb subsection of Fugl-Meyer Assessment is a measure with sound psychometric properties to evaluate motor impairments.

  2. Change scores of Chedoke Arm and Hand Activity Inventory [ Time Frame: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2) ]
    The Chedoke Arm and Hand Activity Inventory is a reliable and validated measure to assess the independence of stroke patients to perform activities of daily living with an affected upper limb.


Secondary Outcome Measures :
  1. change scores of Box and Block Test [ Time Frame: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2) ]
    The Box and Block Test is a tool with sound reliability and validity to evaluate hand dexterity of stroke patients.

  2. change scores of Revised Nottingham Sensory Assessment [ Time Frame: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2) ]
    The Revised Nottingham Sensory Assessment is a standardized measure with good reliability to assess sensory function in patients with stroke.

  3. change scores of Movement Imagery Questionnaire-Revised, Second Edition [ Time Frame: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2) ]
    The Movement Imagery Questionnaire-Revised, Second Edition is a 14-item questionnaire with sound reliability and validity to evaluate the ability of motion imagination in patients with stroke.

  4. change scores of Barthel Index [ Time Frame: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2) ]
    The Barthel Index is a validated tool designed to measure activities reflecting the daily living independence.

  5. change scores of Motor Activity Log [ Time Frame: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2) ]
    The Motor Activity Log is a semi-structured interview with good psychometric properties to assess the level of use of affected upper limb in 30 main activities of daily living.

  6. change scores of the health state of EQ-5D-5L [ Time Frame: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2) ]
    The questionnaire of EQ-5D-5L contains 5 dimensions, including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, and uses a 5-point Likert scale scored from 1 (no problem) to 5 (unable to/extreme problems); whereas, the numerical description of 5 dimensions represents the health state.

  7. change scores of the visual analogue scale (VAS) of EQ-5D-5L [ Time Frame: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2) ]
    The VAS of EQ-5D-5L scores will be scored from 0 to 100, with a higher score indicating better overall current health.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Part Ⅰ: Validation of Treatment Efficacy of the New Digital MT System with Different MVF Conditions and Training Modes

Inclusion Criteria:

  • diagnosed with a unilateral stroke;
  • at least 6 months after stroke onset;
  • age between 20 and 80 years old;
  • having a baseline score of Fugl-Meyer Assessment (FMA) in a range of 20 to 60;
  • able to follow the study instructions;
  • capable of participating in therapy and assessment sessions

Exclusion Criteria:

  • global or receptive aphasia;
  • severe neglect measured by line bisection test;
  • other major medical diseases or comorbidities that have influenced upper-limb usage or caused severe pain

Part II: Investigation of the Electrophysiological Mechanisms Underlying Different MVF Conditions by EEG

Inclusion Criteria:

  • diagnosed with a unilateral stroke;
  • at least 2 weeks after stroke onset and medical stable;
  • aged 20 to 80 years;
  • having a baseline score of FMA ≥ 40 and wrist flexion ≥ 20 degrees in order to perform EEG motor tasks;
  • both wrist flexion and extension scores of Modified Ashworth Scale ≤ 1;
  • able to follow the study instructions

Exclusion Criteria:

  • global or receptive aphasia;
  • severe neglect measured by line bisection test;
  • other major medical diseases or comorbidities, such as neurological and psychiatric diseases, that have caused severe pain of upper-limb or interfered brain neural activities

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04813120


Contacts
Layout table for location contacts
Contact: Yu-Wei Hsieh, PhD +886-3-2118800 ext 3820 ywhsieh@mail.cgu.edu.tw

Locations
Layout table for location information
Taiwan
Lo-Sheng Sanatorium and Hospital Recruiting
Taoyuan City, Taoyuan, Taiwan, 333
Contact: Yu-Wei Hsieh, PhD    +88632118800 ext 3820    ywhsieh@mail.cgu.edu.tw   
Taoyuan Chang Gung Memorial Hospital Recruiting
Taoyuan City, Taiwan, 333
Contact: Yu-Wei Hsieh, PhD    +886-3-2118800 ext 3820    ywhsieh@mail.cgu.edu.tw   
Sponsors and Collaborators
Chang Gung Memorial Hospital
Investigators
Layout table for investigator information
Principal Investigator: Yu-Wei Hsieh, PhD Department of Occupational Therapy, College of Medicine, Chang Gung University
Layout table for additonal information
Responsible Party: Chang Gung Memorial Hospital
ClinicalTrials.gov Identifier: NCT04813120    
Other Study ID Numbers: 202002234A3
First Posted: March 24, 2021    Key Record Dates
Last Update Posted: March 10, 2022
Last Verified: March 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Chang Gung Memorial Hospital:
digital rehabilitation
cerebrovascular accident
mirror visual feedback
brain electrophysiology
Additional relevant MeSH terms:
Layout table for MeSH terms
Stroke
Nervous System Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Brain Diseases
Vascular Diseases
Cardiovascular Diseases